Published in Wien Med Wochenschr on July 01, 2006
Comparison of Cox's Regression Model and Parametric Models in Evaluating the Prognostic Factors for Survival after Liver Transplantation in Shiraz during 2000-2012. Int J Organ Transplant Med (2015) 0.75
Liver transplantation in Greek children: 15 years experience. Pediatr Rep (2010) 0.75
Transection of the oesophagus for bleeding oesophageal varices. Br J Surg (1973) 26.26
Hepatocellular carcinoma. Lancet (2003) 22.54
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46
A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06
HOMOTRANSPLANTATION OF THE LIVER IN HUMANS. Surg Gynecol Obstet (1963) 10.22
Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology (2003) 10.11
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology (2000) 9.74
Early indicators of prognosis in fulminant hepatic failure. Gastroenterology (1989) 7.43
Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl (2005) 4.46
MELD and PELD: application of survival models to liver allocation. Liver Transpl (2001) 3.76
Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology (2004) 3.45
Results of the first year of the new liver allocation plan. Liver Transpl (2004) 2.86
MELD: the holy grail of organ allocation? J Hepatol (2005) 2.35
Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl (2003) 2.04
Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl (2004) 1.58
A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol (2001) 1.49
Prognostic models including the Child-Pugh, MELD and Mayo risk scores--where are we and where should we go? J Hepatol (2004) 1.42
Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation. Liver Transpl (2004) 1.41
Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients. Dig Liver Dis (2000) 1.29
A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras. Aliment Pharmacol Ther (2005) 1.25
Development of the allocation system for deceased donor liver transplantation. Clin Med Res (2005) 1.06
Excellent liver transplant survival rates under the MELD/PELD system. Transplant Proc (2005) 1.01
A prognostic model for patients with end-stage liver disease. Gastroenterology (1997) 0.99
MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis. World J Gastroenterol (2005) 0.98
Host and donor risk factors before and after liver transplantation that impact HCV recurrence. Liver Transpl (2003) 0.85
Summary of guidelines on organ allocation and patient listing for liver transplantation. Liver Transpl Surg (1998) 0.84